Some notable safety-related conclusions from scientific materials include: A 2016 review of TB4 for dermal healing: The safety profile is excellent, and no preclinical toxicology has been found.22 A 2016 clinical trial on patients with STEMI: Our pilot study suggested that T4-optimized EPC transplantation appeared to be feasible and safe.34 A 2021 review of TB4 research: It was well tolerated and safe in healthy people and suitable for use in a clinical study.21 Though the compound itself may be generally safe for adults to use, some common side effects from TB4 injections reported by patients and doctors include: Injection site reactions (e.g., redness, mild swelling, or pain) Mild gastrointestinal symptoms Headaches and dizziness Rare but more serious side effects can include fever, blistering at the injection site, muscle aches, skin rash, vomiting, severe itching, or hives

Strict Use Limitation Not a Drug, Medicine, Supplement, or Consumer Product This product has not been evaluated as a finished combination product for diagnosis, treatment, prevention, mitigation, or cure of any disease
SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature
Frequently Asked Questions What are BPC-157 and KPV
tb infection (Teskey et al., 2018b)
Research protocols typically target 12 mg/mL for intranasal administration